InsidersTradesSigma
Discover the detailed record of transactions filed by Gline Matthew, Chief Executive Officer. Insider active across 1 company, notably Roivant Sciences Ltd.. In total, 6 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €1.7m. Activity tracked since 7 March 2022. The latest transaction was disclosed on 20 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
6 of 6 declarations
Matthew Gline is the Chief Executive Officer of Roivant Sciences Ltd. In this role, he is responsible for the strategic and operational direction of the company. Matthew oversees daily activities and ensures that Roivant achieves its business objectives. His experience in the life sciences sector is essential for guiding the company in its research and development initiatives. He works closely with teams to develop innovative solutions that meet the needs of customers and stakeholders.